4//SEC Filing
Moses Jennifer K. 4
Accession 0000899243-21-000474
CIK 0001560241other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:25 PM ET
Size
7.8 KB
Accession
0000899243-21-000474
Insider Transaction Report
Form 4
Moses Jennifer K.
VP of Finance & Admin
Transactions
- Award
Common Stock
2021-01-04+11,000→ 22,000 total - Award
Stock Options (Right to Buy)
2021-01-04+58,000→ 58,000 totalExercise: $18.07Exp: 2031-01-04→ Common Stock (58,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests 25% on January 4, 2022 and 12.5% semi-annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents 11,000 shares of common stock and 11,000 restricted stock units.
- [F4]The shares underlying this option vest as to 25% of the shares on January 4, 2022, with the remainder vesting in 36 equal installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Documents
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001706667
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:25 PM ET
- Size
- 7.8 KB